WEREWOLF THERAPEUTICS, INC. Cash and Restricted Cash
WEREWOLF THERAPEUTICS, INC. (HOWL) had Cash and Restricted Cash of $21.99 million as of 2026-06-30, per its S-4 filed 2026-09-22.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-09-22
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $21.99M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $47.35M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $57.95M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $66.61M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $21.99M S-4 · filed 2026-09-22 |
| 2026-03-31 | $47.35M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $57.95M S-4 · filed 2026-09-22 |
| 2025-09-30 | $66.61M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $78.49M S-4 · filed 2026-09-22 |
| 2025-03-31 | $93.27M 10-Q · filed 2026-05-07 |
| 2024-12-31 | $112.22M S-4 · filed 2026-09-22 |
| 2024-09-30 | $124.04M 10-Q · filed 2025-11-04 |
| 2024-06-30 | $136.51M 10-Q · filed 2025-08-14 |
| 2024-03-31 | $160.43M 10-Q · filed 2025-05-08 |
| 2023-12-31 | $155.58M S-4 · filed 2026-09-22 |
| 2023-09-30 | $151.29M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $158.68M 10-Q · filed 2024-08-08 |
| 2023-03-31 | $169.09M 10-Q · filed 2024-05-03 |
| 2022-12-31 | $130.53M 10-K · filed 2025-03-11 |
| 2022-09-30 | $141.66M 10-Q · filed 2023-11-14 |
| 2022-06-30 | $147.01M 10-Q · filed 2023-08-10 |
| 2022-03-31 | $145.01M 10-Q · filed 2023-05-11 |
| 2021-12-31 | $158.83M 10-K · filed 2024-03-07 |
| 2021-09-30 | $171.74M 10-Q · filed 2022-11-10 |
| 2021-06-30 | $184.53M 10-Q · filed 2022-08-11 |
| 2021-03-31 | $84.90M 10-Q · filed 2022-05-10 |
| 2020-12-31 | $92.78M 10-K · filed 2023-03-23 |
| 2020-09-30 | $26.91M 10-Q · filed 2021-11-10 |
| 2020-06-30 | $31.99M 10-Q · filed 2021-08-12 |
| 2020-03-31 | $14.26M 10-Q · filed 2021-06-10 |
| 2019-12-31 | $18.10M 10-K · filed 2022-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |